Hereditary Cancer Clinical Trials

4 recruiting

Hereditary Cancer Trials at a Glance

14 actively recruiting trials for hereditary cancer are listed on ClinicalTrialsFinder across 6 cities in 4 countries. The largest study group is Not Applicable with 8 trials, with the heaviest enrollment activity in Boston, New York, and Brooklyn. Lead sponsors running hereditary cancer studies include Dana-Farber Cancer Institute, Weill Medical College of Cornell University, and George Zogopoulos.

Browse hereditary cancer trials by phase

Treatments under study

About Hereditary Cancer Clinical Trials

Looking for clinical trials for Hereditary Cancer? There are currently 4 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Hereditary Cancer trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Hereditary Cancer clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 114 of 14 trials

Recruiting
Not Applicable

Questionnaire on Congenital Cancer Signs Through Self-Assessment

Pediatric CancerHereditary Cancer SyndromesCancer Predisposition Syndromes+1 more
Insel Gruppe AG, University Hospital Bern205 enrolled1 locationNCT07378423
Recruiting

Lynch Syndrome X-Talk of Enteral Mucosa With Immune System

Hereditary Cancer SyndromeHereditary CancerLynch Syndrome+19 more
San Raffaele University300 enrolled5 locationsNCT06708429
Recruiting

Li-Fraumeni & TP53 (LiFT UP): Understanding and Progress

Hereditary Cancer SyndromeLi-Fraumeni SyndromeTP53 Gene Mutation+2 more
Dana-Farber Cancer Institute1,500 enrolled3 locationsNCT04541654
Recruiting
Not Applicable

Closing the GAPS: Guideline Adherence, Prevention and Surveillance in Hereditary Cancer

Hereditary Cancer SyndromesClinical Decision Support
Nest Genomics100 enrolled1 locationNCT06654466
Recruiting
Not Applicable

Feasibility Trial of Combination of Obstetrical Carrier Screening and Hereditary Cancer Screening

Hereditary Cancer Syndrome
Columbia University1,000 enrolled1 locationNCT07195071
Recruiting
Not Applicable

Implementation of Population Cancer Genetic Services in Federally Qualified Health Centers (FQHC)

Hereditary Cancer Syndrome
University of Illinois at Chicago80 enrolled1 locationNCT05664867
Recruiting
Not Applicable

Trial of Combined Obstetric Carrier Screening and Hereditary Cancer Screening

Hereditary Cancer Syndromes
Weill Medical College of Cornell University550 enrolled5 locationsNCT07052266
Recruiting

CfDNA in Hereditary And High-risk Malignancies 2

Hereditary Cancer Syndrome
University Health Network, Toronto1,000 enrolled8 locationsNCT06726642
Recruiting
Not Applicable

Addressing Genomic Disparities in Cancer Survivors

Hereditary CancerGenetic Testing
Rutgers, The State University of New Jersey428 enrolled2 locationsNCT06073626
Recruiting

InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer

Lung CancerCancer RiskCancer Predisposition Syndrome+28 more
Dana-Farber Cancer Institute5,000 enrolled1 locationNCT05463796
Recruiting
Not Applicable

Chatbot to Maximize Hereditary Cancer Genetic Risk Assessment

Hereditary Cancer SyndromeGynecologic Cancer
Weill Medical College of Cornell University150 enrolled4 locationsNCT05562778
Recruiting

Pancreatic Cancer Registry: For Any Person With a Personal or Family History

Pancreatic Cancer, ATM, BRCA, Hereditary Cancer
Johns Hopkins University12,000 enrolled1 locationNCT02886247
Recruiting
Not Applicable

The DIALOGUE Study: Swiss-Korean Billateral Collaboration

Breast CancerOvarian CancerHereditary Cancer
University of Basel228 enrolled8 locationsNCT04214210
Recruiting

Quebec Pancreas Cancer Study

Pancreatic CancerPancreas CancerHereditary Cancer+8 more
George Zogopoulos2,000 enrolled1 locationNCT04104230